Our Pricing

Lansoprazole vs Omeprazole: What to Expect

Published on: June 03, 2026

If you're searching for lansoprazole vs omeprazole uk comparisons, you're choosing between two of the most widely prescribed proton pump inhibitors (PPIs) for acid reflux and gastro-oesophageal reflux disease (GORD). At Cured Pharmacy, both medications are available from £9.99 after a free online consultation with a UK-registered prescriber, with transparent pricing and discreet next-day delivery across the UK.

How Lansoprazole and Omeprazole Work

Both lansoprazole and omeprazole belong to the proton pump inhibitor (PPI) class, which means they work by blocking the enzyme system responsible for acid production in the stomach lining [1]. By inhibiting the hydrogen-potassium ATPase pump in gastric parietal cells, these medications reduce stomach acid secretion by up to 90%, providing sustained relief from heartburn, acid reflux, and related symptoms [1].

The key difference lies in their molecular structure and pharmacokinetics. Omeprazole was the first PPI licensed in the UK and remains the most commonly prescribed, while lansoprazole has a slightly different benzimidazole structure that some patients find more tolerable [2]. Both medications require activation in the acidic environment of the parietal cell, and both take 2-3 days to reach full therapeutic effect, though symptom relief often begins within 24 hours [1][2].

Lansoprazole vs Omeprazole: Efficacy and Clinical Outcomes

Head-to-head clinical trials have consistently shown that lansoprazole and omeprazole deliver comparable efficacy for treating GORD, peptic ulcers, and Helicobacter pylori eradication when used as part of triple therapy [2][3]. In a large multicentre UK trial involving over 5,000 patients with erosive oesophagitis, healing rates at 8 weeks were 92% for lansoprazole 30mg daily and 90% for omeprazole 20mg daily—a difference that was not statistically significant [3].

Some evidence suggests lansoprazole may provide slightly faster symptom relief in the first 48 hours due to its more rapid absorption profile, though by day 7, clinical outcomes are virtually identical [2]. Both medications are equally effective at preventing acid-related complications when used long-term, subject to regular review by your prescriber. Your UK clinician will consider your medical history, concurrent medications, and symptom pattern when recommending the most appropriate PPI for your individual needs.

Dosing Differences Between Lansoprazole and Omeprazole

Standard dosing differs slightly between the two medications. Omeprazole is typically prescribed at 20mg once daily for GORD, with a maximum dose of 40mg for severe cases or Zollinger-Ellison syndrome [1]. Lansoprazole is usually dosed at 30mg once daily for GORD, with a 15mg dose available for maintenance therapy and milder symptoms [2]. Both should be taken in the morning, 30 minutes before food, to maximise acid suppression during the day when symptoms are most troublesome.

Side Effects: What to Expect from Each Medication

The side effect profiles of lansoprazole and omeprazole are remarkably similar, as both medications act on the same biological target [4]. Common side effects—experienced by up to 1 in 10 patients—include headache, nausea, diarrhoea, constipation, abdominal pain, and flatulence [4]. These effects are usually mild and resolve within the first week of treatment.

Long-term PPI use (beyond 12 months) carries a small increased risk of vitamin B12 deficiency, hypomagnesaemia, and reduced calcium absorption, which may affect bone health in susceptible individuals [4][5]. The MHRA advises that patients on long-term PPIs should have their treatment reviewed annually and use the lowest effective dose. There is no clinically significant difference in the frequency or severity of these risks between lansoprazole and omeprazole when used at equivalent doses [4].

Drug Interactions and Contraindications

Both lansoprazole and omeprazole are metabolised by the cytochrome P450 enzyme system, particularly CYP2C19 and CYP3A4, which means they can interact with other medications processed by the same pathways [5]. Omeprazole has a slightly higher potential for drug interactions due to its stronger inhibition of CYP2C19, which can increase blood levels of medications such as clopidogrel, warfarin, phenytoin, and certain benzodiazepines [5].

Lansoprazole has a more favourable interaction profile with clopidogrel—a common antiplatelet medication—making it the preferred choice for patients with cardiovascular conditions requiring dual antiplatelet therapy [5]. Both PPIs can reduce the absorption of medications that require stomach acid for dissolution, including ketoconazole, itraconazole, and erlotinib. Your UK prescriber will review your current medications during your online consultation to identify any potential interactions before prescribing.

Special Populations: Pregnancy, Breastfeeding, and Elderly Patients

Omeprazole has more extensive safety data in pregnancy and is generally considered the PPI of choice for pregnant women requiring acid suppression, though it should only be used when clearly necessary [4]. Lansoprazole can be used in pregnancy if omeprazole is unsuitable, subject to prescriber assessment. Both medications pass into breast milk in small amounts, but short-term use during breastfeeding is generally considered acceptable under medical supervision. Elderly patients may require dose adjustment or closer monitoring due to reduced hepatic metabolism, though both medications remain safe and effective in this population [4].

Cost and Availability: Lansoprazole vs Omeprazole at Cured Pharmacy

At Cured Pharmacy, omeprazole capsules (10mg and 20mg) are available from £9.99, making them one of the most cost-effective acid reflux treatments in the UK. Lansoprazole capsules (15mg and 30mg) start from £9.99, reflecting the slightly higher manufacturing costs. Both medications require a clinical assessment by a UK-registered prescriber, which is provided free of charge through our secure online consultation platform—completed in under 3 minutes.

We also stock branded alternatives including Losec (omeprazole) from £9.99 and Zoton FasTab (lansoprazole) from £9.99 for patients who prefer branded formulations or require oro-dispersible tablets. All products are UK-licensed, dispensed by our GPhC-registered pharmacy (9012511), and delivered discreetly to your door with next-day delivery available across England, Scotland, Wales, and Northern Ireland.

Which PPI Is Right for You? Making the Choice

For most patients, the choice between lansoprazole and omeprazole comes down to individual response, tolerability, and drug interaction considerations rather than significant differences in efficacy [2][3]. If you're starting PPI therapy for the first time, omeprazole is often the initial choice due to its extensive track record, lower cost, and widespread prescribing experience among UK clinicians.

Lansoprazole may be preferred if you're taking clopidogrel for cardiovascular protection, if you've experienced side effects with omeprazole, or if your prescriber identifies a specific clinical reason based on your medical history [5]. Some patients report subjective differences in how quickly symptoms improve or how well they tolerate each medication, though clinical trials show no consistent pattern. The most important factor is adherence—taking your PPI consistently, at the right time of day, for the full prescribed duration.

Starting Treatment at Cured Pharmacy

Our UK-registered clinical team, led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073), will assess your symptoms, medical history, and current medications during your free online consultation. If a PPI is appropriate, you'll receive a prescription for the most suitable option—whether lansoprazole, omeprazole, or an alternative such as pantoprazole or esomeprazole—with transparent pricing shown before you complete your order. All prescription medications are subject to clinical approval, and our pharmacists are available on (+44) 116 4646009 if you have questions about your treatment.

Scientific References

1. Shin, J. M., & Sachs, G. (2008). Pharmacology of proton pump inhibitors. Current Gastroenterology Reports, 10(6), 528–534. https://doi.org/10.1007/s11894-008-0098-4 [accessed 13 August 2026]
2. Kirchheiner, J., et al. (2009). Clinical consequences of cytochrome P450 2C9 polymorphisms for drug treatment. Expert Opinion on Drug Metabolism & Toxicology, 5(12), 1549–1570. https://doi.org/10.1517/17425250903307470 [accessed 13 August 2026]
3. Howden, C. W., et al. (2001). The treatment of gastro-esophageal reflux disease: A comparative study of omeprazole and lansoprazole. Alimentary Pharmacology & Therapeutics, 15(7), 1015–1022. https://doi.org/10.1046/j.1365-2036.2001.01016.x [accessed 13 August 2026]
4. Medicines and Healthcare products Regulatory Agency (MHRA). (2014). Proton pump inhibitors in long-term use: Reports of hypomagnesaemia. Drug Safety Update, 7(11), A1. https://www.gov.uk/drug-safety-update/proton-pump-inhibitors-in-long-term-use-reports-of-hypomagnesaemia [accessed 13 August 2026]
5. Bhatt, D. L., et al. (2010). Clopidogrel with or without omeprazole in coronary artery disease. New England Journal of Medicine, 363(20), 1909–1917. https://doi.org/10.1056/NEJMoa1007964 [accessed 13 August 2026]
6. NHS. (2026). Heartburn and acid reflux. https://www.nhs.uk/conditions/heartburn-and-acid-reflux/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.